A Multicenter Phase III Study to Investigate the Safety and Efficacy of Treanda )Bendamustine HC1) in Patients with Indolent Non-Hodgkin's Lymphoma (NHL) who are Refractory to Rituximab (SDX-105-03)

  • McDonagh, Kevin (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/06 → 8/31/10